and target validation
Discovering and validating novel target molecules and uncovering unique epitopes that define their role in a disease are key challenges faced by our industry. A deep understanding of the disease biology is a prerequisite for fulfilling this task successfully. MorphoSys has been active in oncology, both hematological malignancies and solid tumors, as well as in inflammatory and autoimmune diseases for several years. Taking into account the numerous partnered programs, MorphoSys has had exposure to an even broader spectrum of indications..